Literature DB >> 32557808

Investigating biases in the measurement of apparent alveolar septal wall thickness with hyperpolarized 129Xe MRI.

Kai Ruppert1, Faraz Amzajerdian1,2, Yi Xin1,2, Hooman Hamedani1,2, Luis Loza1, Tahmina Achekzai1, Ian F Duncan1, Harrilla Profka1, Yiwen Qian, Mehrdad Pourfathi1,3, Stephen Kadlecek1, Rahim R Rizi1.   

Abstract

PURPOSE: To investigate biases in the measurement of apparent alveolar septal wall thickness (SWT) with hyperpolarized xenon-129 (HXe) as a function of acquisition parameters.
METHODS: The HXe MRI scans with simultaneous gas-phase and dissolved-phase excitation were performed using 1-dimensional projection scans in mechanically ventilated rabbits. The dissolved-phase magnetization was periodically saturated, and the dissolved-phase xenon uptake dynamics were measured at end inspiration and end expiration with temporal resolutions up to 10 ms using a Look-Locker-type acquisition. The apparent alveolar septal wall thickness was extracted by fitting the signal to a theoretical model, and the findings were compared with those from the more commonly use chemical shift saturation recovery MRI spectroscopy technique with several different delay time arrangements.
RESULTS: It was found that repeated application of RF saturation pulses in chemical shift saturation recovery acquisitions caused exchange-dependent gas-phase saturation that heavily biased the derived SWT value. When this bias was reduced by our proposed method, the SWT dependence on lung inflation disappeared due to an inherent insensitivity of HXe dissolved-phase MRI to thin alveolar structures with very short T 2 ∗ . Furthermore, perfusion-based macroscopic gas transport processes were demonstrated to cause increasing apparent SWTs with TE (2.5 μm/ms at end expiration) and a lung periphery-to-center SWT gradient.
CONCLUSION: The apparent SWT measured with HXe MRI was found to be heavily dependent on the acquisition parameters. A method is proposed that can minimize this measurement bias, add limited spatial resolution, and reduce measurement time to a degree that free-breathing studies are feasible.
© 2020 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  dissolved-phase imaging; hyperpolarized xenon-129; lung MRI; pulmonary gas uptake quantification

Year:  2020        PMID: 32557808      PMCID: PMC8088830          DOI: 10.1002/mrm.28329

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  56 in total

1.  Imaging alveolar-capillary gas transfer using hyperpolarized 129Xe MRI.

Authors:  Bastiaan Driehuys; Gary P Cofer; Jim Pollaro; Julie Boslego Mackel; Laurence W Hedlund; G Allan Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

2.  Homodyne detection in magnetic resonance imaging.

Authors:  D C Noll; D G Nishimura; A Macovski
Journal:  IEEE Trans Med Imaging       Date:  1991       Impact factor: 10.048

3.  MR imaging and spectroscopy using hyperpolarized 129Xe gas: preliminary human results.

Authors:  J P Mugler; B Driehuys; J R Brookeman; G D Cates; S S Berr; R G Bryant; T M Daniel; E E de Lange; J H Downs; C J Erickson; W Happer; D P Hinton; N F Kassel; T Maier; C D Phillips; B T Saam; K L Sauer; M E Wagshul
Journal:  Magn Reson Med       Date:  1997-06       Impact factor: 4.668

4.  Enabling hyperpolarized (129) Xe MR spectroscopy and imaging of pulmonary gas transfer to the red blood cells in transgenic mice expressing human hemoglobin.

Authors:  Matthew S Freeman; Zackary I Cleveland; Yi Qi; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

5.  Using Hyperpolarized Xenon-129 MRI to Quantify Early-Stage Lung Disease in Smokers.

Authors:  Kai Ruppert; Kun Qing; James T Patrie; Talissa A Altes; John P Mugler
Journal:  Acad Radiol       Date:  2018-12-03       Impact factor: 3.173

6.  Hyperpolarized Xenon-129 gas-exchange imaging of lung microstructure: first case studies in subjects with obstructive lung disease.

Authors:  Isabel Dregely; John P Mugler; Iulian C Ruset; Talissa A Altes; Jaime F Mata; G Wilson Miller; Jeffrey Ketel; Steve Ketel; Jan Distelbrink; F W Hersman; Kai Ruppert
Journal:  J Magn Reson Imaging       Date:  2011-05       Impact factor: 4.813

7.  Finite element modeling of (129)Xe diffusive gas exchange NMR in the human alveoli.

Authors:  Neil J Stewart; Juan Parra-Robles; Jim M Wild
Journal:  J Magn Reson       Date:  2016-07-27       Impact factor: 2.229

8.  Direct imaging of hyperpolarized 129Xe alveolar gas uptake in a mouse model of emphysema.

Authors:  Satoshi Iguchi; Hirohiko Imai; Yuki Hori; Junichi Nakajima; Atsuomi Kimura; Hideaki Fujiwara
Journal:  Magn Reson Med       Date:  2012-08-08       Impact factor: 4.668

9.  Abnormalities in hyperpolarized (129)Xe magnetic resonance imaging and spectroscopy in two patients with pulmonary vascular disease.

Authors:  Talal Dahhan; Shiv S Kaushik; Mu He; Joseph G Mammarappallil; Victor F Tapson; Holman P McAdams; Thomas A Sporn; Bastiaan Driehuys; Sudarshan Rajagopal
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

10.  Hyperpolarized Xe MR imaging of alveolar gas uptake in humans.

Authors:  Zackary I Cleveland; Gary P Cofer; Gregory Metz; Denise Beaver; John Nouls; S Sivaram Kaushik; Monica Kraft; Jan Wolber; Kevin T Kelly; H Page McAdams; Bastiaan Driehuys
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

View more
  2 in total

1.  Measuring pulmonary gas exchange using compartment-selective xenon-polarization transfer contrast (XTC) MRI.

Authors:  Faraz Amzajerdian; Kai Ruppert; Hooman Hamedani; Ryan Baron; Yi Xin; Luis Loza; Tahmina Achekzai; Ian F Duncan; Yiwen Qian; Mehrdad Pourfathi; Stephen Kadlecek; Rahim R Rizi
Journal:  Magn Reson Med       Date:  2020-12-07       Impact factor: 4.668

Review 2.  In vivo methods and applications of xenon-129 magnetic resonance.

Authors:  Helen Marshall; Neil J Stewart; Ho-Fung Chan; Madhwesha Rao; Graham Norquay; Jim M Wild
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-12-09       Impact factor: 9.795

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.